SCHEMBL472968

SCHEMBL472968

C=Cc1ncccc1CC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
KDM4E B2RXH2 5/20 0.36
ALDH1A1 P00352 2/20 0.36
GABRA1 P14867 2/20 0.35
GABRB2 P47870 2/20 0.35
HTR1A P08908 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
SLC40A1 Q9NP59 1/20 0.35
MAPT P10636 4/20 0.34
CYP1A2 P05177 1/20 0.34
TDP1 Q9NUW8 2/20 0.33
GAA P10253 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
GMNN O75496 1/20 0.32
TP53 P04637 1/20 0.32
HSP90AA1 P07900 1/20 0.32
MMP2 P08253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28102473 0.82 CYP2D6 (0.40) SMN1; SMN2L3MBTL1ALDH1A1CYP1A2TDP1
SCHEMBL6115316 0.82 TRIM24 (0.39) LMNASMN1; SMN2L3MBTL1KDM4EALDH1A1
SCHEMBL659486 0.82 GABRA1 (0.37) LMNASMN1; SMN2L3MBTL1KDM4EALDH1A1
SCHEMBL19067831 0.81 GABRA1 (0.42) LMNASMN1; SMN2L3MBTL1KDM4EALDH1A1
SCHEMBL9466495 0.80 THRA (0.41) L3MBTL1TDP1CYP3A4CYP2D6
SCHEMBL1165354 0.80 ALDH1A1 (0.42) LMNAL3MBTL1KDM4EALDH1A1GABRA1
SCHEMBL9070356 0.79 LIPG (0.44) L3MBTL1KDM4EMAPTTDP1MMP2
Benzene SCHEMBL11824212 0.78 TRIM24 (0.37) LMNASMN1; SMN2L3MBTL1KDM4EALDH1A1
SCHEMBL21759880 0.78 KDM4E (0.35) LMNASMN1; SMN2L3MBTL1KDM4EALDH1A1
SCHEMBL11830127 0.78 KDM4E (0.35) LMNASMN1; SMN2L3MBTL1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 191 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103781808-B Soil adsorbing polymers 宝洁公司 2016-11-09 CN claimed
US-9162907-B2 Ion exchanger, method of manufacturing the same, and ion exchange filter device and electro-deionization device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-10-20 US claimed
US-20130264209-A1 ION EXCHANGER, METHOD OF MANUFACTURING THE SAME, AND ION EXCHANGE FILTER DEVICE AND ELECTRO-DEIONIZATION DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2013-10-10 US claimed
EP-2647431-A1 Ion exchanger, method of manufacturing the same, and ion exchange filter device and electro-deionization device including the same Samsung Electronics Co., Ltd (KR) 2013-10-09 EP claimed
EP-1869110-A2 NANOCOMPOSITE-FOAM MATERIAL BASF AKTIENGESELLSCHAFT (DE) 2007-12-26 EP claimed
WO-2006106104-A2 NANOCOMPOSITE-FOAM MATERIAL BASF AKTIENGESELLSCHAFT (DE) 2006-10-12 WO claimed
US-20060160954-A1 Preparation of graft copolymers by sequential polymerization using peroxide-containing polyolefins BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2006-07-20 US claimed
US-20060128824-A1 Irradiation process for making graft copolymers by sequential polymerization BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2006-06-15 US claimed
US-20060051648-A1 Solid polymer electrolyte membrane, method for producing the same, and fuel cell including the solid poymer electrolyte membrane SAMSUNG SDI CO. LTD. (KR) 2006-03-09 US claimed
WO-2005063376-A1 PROCESS FOR MAKING PEROXIDE-CONTAINING OLEFIN POLYMERS Basell Poliolefine Italia, s.r.l. (US) 2005-07-14 WO claimed
EP-0787750-B1 Poly(alkylethylene) structural isomers BOREALIS GMBH (AT) 2003-05-14 EP claimed
EP-1266047-A1 METHOD FOR PROVIDING METAL SURFACES WITH PROTECTION AGAINST CORROSION Henkel Kommanditgesellschaft auf Aktien (DE) 2002-12-18 EP claimed
EP-0806439-B1 Process for making propylene graft copolymers using a redox initiator system BASELL NORTH AMERICA INC (US) 2002-09-11 EP claimed
WO-2001066827-A1 METHOD FOR PROVIDING METAL SURFACES WITH PROTECTION AGAINST CORROSION HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2001-09-13 WO claimed
US-5871722-A CROSSLINKING A CATIONIC POLYMERS FOR KERATIN ADVANCED POLYMER SYSTEMS, INC. (US) 1999-02-16 US claimed
US-5840293-A TOPICAL COMPOSITION COMPRISING CARRIER WITH DISPERSED NONCOLLAPSIBLE CROSSLINKED POLYMERIC BEADS HAVING NETWORK OF INTERNAL PORES CONTAINING ACTIVE SUBSTANCE AND EXTERIOR SURFACE CHARGE WHICH PROMOTES ADHESION TO KERATINIC MATERIALS ADVANCED POLYMER SYSTEMS, INC. (US) 1998-11-24 US claimed
US-5817707-A RADIATION; CONTROLLED OXIDATION; HEATING; DISPENSING IN WATER; ADDING VINYL MONOMER MONTELL NORTH AMERICA INC. (US) 1998-10-06 US claimed
EP-0806439-A2 Process for making propylene graft copolymers using a redox initiator system MONTELL NORTH AMERICA INC. (US) 1997-11-12 EP claimed
US-4680357-A ADHESIVES THE DOW CHEMICAL COMPANY (US) 1987-07-14 US claimed
US-20250332546-A1 ION EXCHANGE MEMBRANE, METHOD FOR MANUFACTURING ION EXCHANGE MEMBRANE, AND ION EXCHANGE MEMBRANE CELL UNIV YAMAGUCHI (JP) 2025-10-30 US disclosed
US-12018002-B2 Certain chemical entities, compositions, and methods NEUPHARMA, INC (US) 2024-06-25 US disclosed
EP-4331710-A1 ION EXCHANGE MEMBRANE, METHOD FOR MANUFACTURING ION EXCHANGE MEMBRANE, AND ION EXCHANGE MEMBRANE CELL Yamaguchi University (JP) 2024-03-06 EP disclosed
US-20230148061-A1 TEAD INHIBITORS AND USES THEREOF THE EHE FOUNDATION 2023-05-11 US disclosed
US-20230119424-A1 ANION EXCHANGE MEMBRANE AND METHOD FOR PRODUCING SAME ASTOM CORPORATION (JP) 2023-04-20 US disclosed
WO-2023064493-A1 COMPOUNDS AND METHODS FOR TREATING CORONAVIRUSES Clear Creek Bio, Inc. (US) 2023-04-20 WO disclosed
US-20230043970-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NEUPHARMA, INC 2023-02-09 US disclosed
EP-4119601-A1 ANION EXCHANGE MEMBRANE AND METHOD FOR PRODUCING SAME Astom Corporation (JP) 2023-01-18 EP disclosed
CN-115298249-A Anion exchange membrane and method for producing same 株式会社亚斯通 2022-11-04 CN disclosed
WO-2022230998-A1 ION EXCHANGE MEMBRANE, METHOD FOR MANUFACTURING ION EXCHANGE MEMBRANE, AND ION EXCHANGE MEMBRANE CELL 国立大学法人山口大学 2022-11-03 WO disclosed
US-11358940-B2 K-Ras modulators THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-06-14 US disclosed
US-11008334-B2 Compositions and methods for treating cancer THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-05-18 US disclosed
US-10857140-B2 K-Ras modulators THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-12-08 US disclosed
US-20200255446-A1 COMPOSITIONS AND METHODS FOR TREATING CANCER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2020-08-13 US disclosed
US-20200247762-A1 K-RAS MODULATORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2020-08-06 US disclosed
CN-108884266-A The rubber through being compounded of heat transmitting with improvement 卡博特公司 2018-11-23 CN disclosed
US-9162907-B2 Ion exchanger, method of manufacturing the same, and ion exchange filter device and electro-deionization device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-10-20 US disclosed
EP-2412751-B1 ION EXCHANGE BODY AND PRODUCTION METHOD THEREFOR ASTOM CORP (JP) 2014-09-03 EP disclosed
US-20130264209-A1 ION EXCHANGER, METHOD OF MANUFACTURING THE SAME, AND ION EXCHANGE FILTER DEVICE AND ELECTRO-DEIONIZATION DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2013-10-10 US disclosed
EP-2647431-A1 Ion exchanger, method of manufacturing the same, and ion exchange filter device and electro-deionization device including the same Samsung Electronics Co., Ltd (KR) 2013-10-09 EP disclosed
US-8530018-B2 Ion exchanger and method of producing the same ASTOM CORPORATION (JP) 2013-09-10 US disclosed
US-20130072469-A1 HETEROARYL COMPOUNDS AND USES THEREOF CELGENE AVILOMICS RESEARCH, INC. (US) 2013-03-21 US disclosed
US-20130065899-A1 HETEROARYL COMPOUNDS AND USES THEREOF CELGENE AVILOMICS RESEARCH, INC. (US) 2013-03-14 US disclosed
US-20130065892-A1 HETEROARYL COMPOUNDS AND USES THEREOF CELGENE AVILOMICS RESEARCH, INC. (US) 2013-03-14 US disclosed
US-20130017991-A1 HCV PROTEASE INHIBITORS AND USES THEREOF CELGENE AVILOMICS RESEARCH, INC. (US) 2013-01-17 US disclosed
US-8329901-B2 4,6-disubstitued pyrimidines useful as kinase inhibitors CELGENE AVILOMICS RESEARCH, INC. (US) 2012-12-11 US disclosed
US-8309685-B2 HCV protease inhibitors and uses thereof CELGENE AVILOMICS RESEARCH, INC. (US) 2012-11-13 US disclosed
US-8293705-B2 HCV protease inhibitors and uses thereof AVILA THERAPEUTICS, INC. (US) 2012-10-23 US disclosed
US-20120258967-A1 PI3 KINASE INHIBITORS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2012-10-11 US disclosed
US-20120238593-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2012-09-20 US disclosed
US-8242271-B2 Heterocyclic compounds and uses thereof AVILA THERAPEUTICS, INC. (US) 2012-08-14 US disclosed
US-20120190614-A1 HCV PROTEASE INHIBITORS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2012-07-26 US disclosed
US-8188137-B2 HCV protease inhibitors and uses thereof AVILA THERAPEUTICS, INC. (US) 2012-05-29 US disclosed
EP-2412751-A1 ION EXCHANGE BODY AND PRODUCTION METHOD THEREFOR Astom Corporation (JP) 2012-02-01 EP disclosed
US-20110230494-A1 HETEROARYL COMPOUNDS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2011-09-22 US disclosed
US-20110230476-A1 PI3 KINASE INHIBITORS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2011-09-22 US disclosed
US-20110224432-A1 HETEROARYL COMPOUNDS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2011-09-15 US disclosed
US-7989465-B2 4,6-disubstituted pyrimidines useful as kinase inhibitors AVILA THERAPEUTICS, INC. (US) 2011-08-02 US disclosed
US-7982036-B2 4,6-disubstitued pyrimidines useful as kinase inhibitors AVILA THERAPEUTICS, INC. (US) 2011-07-19 US disclosed
US-20110117073-A1 Protein Kinase Conjugates and Inhibitors AVILA THERAPEUTICS, INC. (US) 2011-05-19 US disclosed
US-20100249092-A1 HETEROARYL COMPOUNDS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2010-09-30 US disclosed
US-20100185419-A1 ALGORITHM FOR DESIGNING IRREVERSIBLE INHIBITORS AVILA THERAPEUTICS, INC. (US) 2010-07-22 US disclosed
US-20100069294-A1 HCV PROTEASE INHIBITORS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2010-03-18 US disclosed
US-20100041674-A1 HCV PROTEASE INHIBITORS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2010-02-18 US disclosed
US-20100041591-A1 HCV PROTEASE INHIBITORS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2010-02-18 US disclosed
US-20100029610-A1 Heteroaryl Compounds and Uses Thereof AVILA THERAPEUTICS, INC. (US) 2010-02-04 US disclosed
US-20100016296-A1 HETEROARYL COMPOUNDS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2010-01-21 US disclosed
US-20090306085-A1 HCV PROTEASE INHIBITORS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2009-12-10 US disclosed
US-20090176858-A1 HCV PROTEASE INHIBITORS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2009-07-09 US disclosed
US-20090137588-A1 HETEROARYL COMPOUNDS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2009-05-28 US disclosed
US-20090081696-A1 LUMINESCENCE ENHANCER AND USE THEREOF FUJIREBIO INC. (JP) 2009-03-26 US disclosed
EP-2028250-A1 LUMINESCENCE ENHANCER FUJIREBIO INC. (JP) 2009-02-25 EP disclosed
US-20080300268-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2008-12-04 US disclosed
EP-1869110-A2 NANOCOMPOSITE-FOAM MATERIAL BASF AKTIENGESELLSCHAFT (DE) 2007-12-26 EP disclosed
EP-1127083-B1 POLYOLEFIN GRAFT COPOLYMERS MADE WITH FLUORINATED MONOMERS CHEMTURA CORP (US) 2007-09-12 EP disclosed
EP-1756174-A1 PROCESS FOR ENRICHING THE PEROXIDE CONTENT OF PEROXIDE-CONTAINING POLYOLEFINS VIA REACTIVATION Basell Poliolefine Italia S.r.l. (IT) 2007-02-28 EP disclosed
WO-2006106104-A2 NANOCOMPOSITE-FOAM MATERIAL BASF AKTIENGESELLSCHAFT (DE) 2006-10-12 WO disclosed
US-20060178464-A1 Polyolefin nanocomposite compositions BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2006-08-10 US disclosed
US-20060160954-A1 Preparation of graft copolymers by sequential polymerization using peroxide-containing polyolefins BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2006-07-20 US disclosed
US-20060128824-A1 Irradiation process for making graft copolymers by sequential polymerization BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2006-06-15 US disclosed
US-20060051648-A1 Solid polymer electrolyte membrane, method for producing the same, and fuel cell including the solid poymer electrolyte membrane SAMSUNG SDI CO. LTD. (KR) 2006-03-09 US disclosed
EP-1606346-A1 POLYOLEFIN NANOCOMPOSITE COMPOSITIONS Basell Poliolefine Italia S.r.l. (IT) 2005-12-21 EP disclosed
WO-2005116091-A1 PROCESS FOR ENRICHING THE PEROXIDE CONTENT OF PEROXIDE-CONTAINING POLYOLEFINS VIA REACTIVATION BASELL POLIOLEFINE ITALIA S.R.L. (US) 2005-12-08 WO disclosed
WO-2005063376-A1 PROCESS FOR MAKING PEROXIDE-CONTAINING OLEFIN POLYMERS Basell Poliolefine Italia, s.r.l. (US) 2005-07-14 WO disclosed
EP-1056807-B1 POLYPROPYLENE GRAFT COPOLYMERS WITH IMPROVED SCRATCH AND MAR RESISTANCE BASELL POLIOLEFINE SPA (IT) 2005-01-26 EP disclosed
WO-2004113406-A1 PROCESS FOR MAKING GRAFT COPOLYMERS IN MOLTEN STATE USING A REACTIVE, PEROXIDE-CONTAINING OLEFIN POLYMER BASELL POLIOLEFINE ITALIA S.R.L. (US) 2004-12-29 WO disclosed
EP-1276801-B1 COMPOSITE MATERIALS COMPRISING PROPYLENE GRAFT COPOLYMERS BASELL POLIOLEFINE SPA (IT) 2004-10-27 EP disclosed
US-6806319-B2 BLENDING, BEFORE MELT PROCESSING, A POLYMER WITH UNSATURATED ALIPHATIC COMPOUND HAVING A MOLECULAR WEIGHT OF AT LEAST 200 AND AN IODINE NUMBER OF AT LEAST 10, E.G., SOYBEAN OIL BASELL POLIOELFINE ITALIA S.P.A. (IT) 2004-10-19 US disclosed
WO-2004085534-A1 POLYOLEFIN NANOCOMPOSITE COMPOSITIONS BASELL POLIOLEFINE ITALIA S.R.L. (US) 2004-10-07 WO disclosed
US-6800694-B2 POLYOLEFIN GRAFT WITH A FLUORINATED GASEOUS MONOMER SUCH AS VINYLIDENE FLUORIDE, AND OPTIONALLY A NON-FLUORINATED MONOMER SUCH AS METHYL METHACRYLATE; IMPROVED WEAR RESISTANCE, OXYGEN BARRIER PROPERTIES, AND HEAT RESISTANCE BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2004-10-05 US disclosed
EP-1421124-A1 CONTROLLING THE MOLECULAR WEIGHT OF GRAFT COPOLYMERS USING POLYMERIZABLE CHAIN TRANSFER AGENTS Basell Poliolefine Italia S.P.A. (IT) 2004-05-26 EP disclosed
US-6667367-B1 Grafted with polymerized vinyl monomers; injection molding materials; paint adhesion and durability BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2003-12-23 US disclosed
EP-1363959-A1 MAKING POLYOLEFIN GRAFT COPOLYMERS WITH LOW MOLECULAR WEIGHT SIDE CHAINS USING A POLYMERIC PEROXIDE AS AN INITIATOR Basell Poliolefine Italia S.p.A. (IT) 2003-11-26 EP disclosed
EP-0899277-B1 Process for making polypropylene graft copolymers containing anhydride groups BASELL NORTH AMERICA INC (US) 2003-11-12 EP disclosed
EP-1330478-A1 IRRADIATION PROCESS FOR MAKING OLEFIN GRAFT COPOLYMERS WITH LOW MOLECULAR WEIGHT SIDE CHAINS Basell Poliolefine Italia S.p.A. (IT) 2003-07-30 EP disclosed
EP-1325077-A1 DIRECTLY PAINTABLE POLYPROPYLENE GRAFT COPOLYMERS Basell Poliolefine Italia S.p.A. (IT) 2003-07-09 EP disclosed
US-20030125436-A1 Retarding the thermal degradation of polymers using unsaturated aliphatic compounds BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2003-07-03 US disclosed
EP-0924228-B1 Morphology control in polypropylene graft copolymers BASELL NORTH AMERICA INC (US) 2003-06-04 EP disclosed
EP-0787750-B1 Poly(alkylethylene) structural isomers BOREALIS GMBH (AT) 2003-05-14 EP disclosed
EP-0905155-B1 Using nitric oxide to reduce reactor fouling during polypropylene graft copolymerization BASELL NORTH AMERICA INC (US) 2003-02-26 EP disclosed
WO-2003014175-A1 CONTROLLING THE MOLECULAR WEIGHT OF GRAFT COPOLYMERS USING POLYMERIZABLE CHAIN TRANSFER AGENTS BASELL POLIOLEFINE ITALIA S.P.A. (US) 2003-02-20 WO disclosed
US-6518327-B1 Graft copolymers were made from a propylene homopolymer to which was graft polymerized polystyrene or poly(methyl methacylate) in the prsence of a hydroxylamine polymerization inhibitor BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2003-02-11 US disclosed
EP-1276801-A2 COMPOSITE MATERIALS COMPRISING PROPYLENE GRAFT COPOLYMERS Basell Poliolefine Italia S.p.A. (IT) 2003-01-22 EP disclosed
US-6506847-B1 Treating propylene polymer with free radical initiator; graft polymerization with vinyl monomer; chain transfer using allyl ether or allyl ester; removing unreacted monomer, decomposing deactivating initiator and free radicals BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2003-01-14 US disclosed
EP-0819709-B1 Process for producing polyolefin grafted copolymers BASELL NORTH AMERICA INC (US) 2002-11-13 EP disclosed
US-6451897-B1 Nanocomposites made from polypropylene graft copolymers BASELL TECHNOLOGY COMPANY BV (NL) 2002-09-17 US disclosed
EP-0806439-B1 Process for making propylene graft copolymers using a redox initiator system BASELL NORTH AMERICA INC (US) 2002-09-11 EP disclosed
US-6444722-B1 PROCESS CONTROL BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2002-09-03 US disclosed
US-6388020-B2 MODIFIED WITH LESS THAN 5% BY WEIGHT OF MONOFUNCTIONAL, DIFUNCTIONAL AND POLYFUNCTIONAL MONOMERS; IMPROVED MELT PROCESSABILITY; SHEETS, FILMS, PANELS, COATINGS, PIPES, HOLLOW OBJECTS AND FOAMS BOREALIS GMBH (AT) 2002-05-14 US disclosed
WO-2002036649-A1 MAKING POLYOLEFIN GRAFT COPOLYMERS WITH LOW MOLECULAR WEIGHT SIDE CHAINS USING A POLYMERIC PEROXIDE AS AN INITIATOR BASELL TECHNOLOGY COMPANY B.V. (US) 2002-05-10 WO disclosed
WO-2002036650-A1 IRRADIATION PROCESS FOR MAKING OLEFIN GRAFT COPOLYMERS WITH LOW MOLECULAR WEIGHT SIDE CHAINS BASELL TECHNOLOGY COMPANY B.V. (US) 2002-05-10 WO disclosed
WO-2002031052-A1 DIRECTLY PAINTABLE POLYPROPYLENE GRAFT COPOLYMERS BASELL TECHNOLOGY COMPANY B.V. (US) 2002-04-18 WO disclosed
US-20020028884-A1 Polyolefin graft copolymers made with fluorinated monomers ADDIVANT USA, LLC 2002-03-07 US disclosed
US-6337373-B1 FLUOROPOLYMERS AND ACRYLONITRILE GRAFT POLYMERS MONTELL TECHNOLOGY COMPANY BV (NL) 2002-01-08 US disclosed
WO-2001096467-A2 COMPOSITE MATERIALS COMPRISING PROPYLENE GRAFT COPOLYMERS BASELL TECHNOLOGY COMPANY B.V. (US) 2001-12-20 WO disclosed
EP-0781551-B1 Retinoid formulations in porous microspheres for reduced irritation and enhanced stability ENHANCED DERM TECHNOLOGIES INC (US) 2001-11-21 EP disclosed
EP-1127083-A1 POLYOLEFIN GRAFT COPOLYMERS MADE WITH FLUORINATED MONOMERS Basell Technology Company B.V. (NL) 2001-08-29 EP disclosed
US-20010016628-A1 Modified with less than 5% by weight of monofunctional, difunctional and polyfunctional monomers; improved melt processability; sheets, films, panels, coatings, pipes, hollow objects and foams BOREALIS GMBH (AU) 2001-08-23 US disclosed
WO-2001009209-A1 POLYOLEFIN GRAFT COPOLYMERS MADE WITH FLUORINATED MONOMERS BASELL TECHNOLOGY COMPANY B.V. (US) 2001-02-08 WO disclosed
US-6177515-B1 BLEND WITH LOW MOLECULAR WEIGHT ETHYLENE POLYMER OPTIONALLY CONTAINING INORGANIC MICROSPHERES MONTELL TECHNOLOGY COMPANY BV (NL) 2001-01-23 US disclosed
EP-1056807-A1 POLYPROPYLENE GRAFT COPOLYMERS WITH IMPROVED SCRATCH AND MAR RESISTANCE Montell Technology Company B.V. (NL) 2000-12-06 EP disclosed
US-6140425-A DEHYDRATION OF SUBSTITUTED ACRYLIC ACID UNITS GRAFT POLYMERIZED ONTO A POLYPROPYLENE BACKBONE TO FORM ANHYDRIDE GROUPS MONTELL NORTH AMERICA INC. (US) 2000-10-31 US disclosed
US-6136926-A CURING WITH ETHYLENICALLY UNSATURATED ORGANOSILANE COMPOUND; HEATING BELOW SOFTENING POINT BOREALIS GMBH (AT) 2000-10-24 US disclosed
WO-2000036012-A1 POLYPROPYLENE GRAFT COPOLYMERS WITH IMPROVED SCRATCH AND MAR RESISTANCE MONTELL TECHNOLOGY COMPANY BV (US) 2000-06-22 WO disclosed
US-5980878-A A WATER OR ALCOHOL SOLUBLE OR DISPERSIBLE RANDOM COPOLYMERS COMPRISING A HYDROPHILIC MACROMONOMER UNITS HAVING UNSATURATED ALKYL QUATERNIZED NITROGEN GROUP; FOR HAIR STYLING, TOPICAL SKIN CARE FOR DRUG DELIVERY, TRANSDERMAL THE PROCTER & GAMBLE COMPANY (US) 1999-11-09 US disclosed
US-5942194-A SOLVENT-FREE GAS PHASE PRODUCTION MONTELL NORTH AMERICA INC. (US) 1999-08-24 US disclosed
US-5919439-A USEFUL FOR DELIVERING AND/OR TRANSDERMALLY TRANSPORTING ACTIVE INGREDIENTS; HAIR STYLING THE PROCTER & GAMBLE COMPANY (US) 1999-07-06 US disclosed
US-5916974-A POLYMERIZATION RATE MODIFIER CAPABLE OF FUNCTIONING IN A SUBSTANTIALLY NON-OXIDIZING ENVIRONMENT MONTELL NORTH AMERICA INC. (US) 1999-06-29 US disclosed
US-5916547-A WATER OR ALCOHOL SOLUBLE THE PROCTER & GAMBLE COMPANY (US) 1999-06-29 US disclosed
EP-0924228-A1 Morphology control in polypropylene graft copolymers MONTELL NORTH AMERICA INC. (US) 1999-06-23 EP disclosed
EP-0905155-A1 Using nitric oxide to reduce reactor fouling during polypropylene graft copolymerization MONTELL NORTH AMERICA INC. (US) 1999-03-31 EP disclosed
EP-0665248-B1 A process for sequentially grafting olefin polymer materials and grafted polymers therefrom MONTELL NORTH AMERICA INC (US) 1999-03-31 EP disclosed
EP-0899277-A1 Process for making polypropylene graft copolymers containing anhydride groups MONTELL NORTH AMERICA INC. (US) 1999-03-03 EP disclosed
US-5871722-A CROSSLINKING A CATIONIC POLYMERS FOR KERATIN ADVANCED POLYMER SYSTEMS, INC. (US) 1999-02-16 US disclosed
US-5863994-A REDUCES BUILD-UP OF POLYMER DEPOSITS ON REACTOR WALLS AND GAS CIRCULATION LOOPS WHILE HAVING ALMOST NO EFFECT ON THE GRAFT COPOLYMERIZATION REACTION MONTELL NORTH AMERICA INC. (US) 1999-01-26 US disclosed
US-5851538-A Retinoid formulations in porous microspheres for reduced irritation and enhanced stability ADVANCED POLYMER SYSTEMS, INC. (US) 1998-12-22 US disclosed
US-5840293-A TOPICAL COMPOSITION COMPRISING CARRIER WITH DISPERSED NONCOLLAPSIBLE CROSSLINKED POLYMERIC BEADS HAVING NETWORK OF INTERNAL PORES CONTAINING ACTIVE SUBSTANCE AND EXTERIOR SURFACE CHARGE WHICH PROMOTES ADHESION TO KERATINIC MATERIALS ADVANCED POLYMER SYSTEMS, INC. (US) 1998-11-24 US disclosed
US-5817707-A RADIATION; CONTROLLED OXIDATION; HEATING; DISPENSING IN WATER; ADDING VINYL MONOMER MONTELL NORTH AMERICA INC. (US) 1998-10-06 US disclosed
US-5730966-A WATER OR ALCOHOL SOLUBLE OR DISPERSIBLE COPOLYMER FOR STYLING HAIR THE PROCTER & GAMBLE COMPANY (US) 1998-03-24 US disclosed
EP-0821018-A2 Crosslinkable olefinic polymers and method for their preparation PCD-Polymere Gesellschaft m.b.H. (AT) 1998-01-28 EP disclosed
EP-0819709-A2 Process for producing polyolefin grafted copolymers MONTELL NORTH AMERICA INC. (US) 1998-01-21 EP disclosed
US-5696203-A FREE RADICAL POLYMERIZATION MONTELL NORTH AMERICA INC. (US) 1997-12-09 US disclosed
EP-0806439-A2 Process for making propylene graft copolymers using a redox initiator system MONTELL NORTH AMERICA INC. (US) 1997-11-12 EP disclosed
EP-0792894-A2 Continuous modification of polyolefins in solid phase PCD-Polymere Gesellschaft m.b.H. (AT) 1997-09-03 EP disclosed
EP-0787750-A2 Poly(alkylethylene) structural isomers PCD-Polymere Gesellschaft m.b.H. (AT) 1997-08-06 EP disclosed
US-5652281-A IRRADIATION OF POLYMER PARTICLES TO FORM FREE RADICAL SITES, REACTION WITH MONOMER, UNIFORM DISTRIBUTION OF GRAFT POLYMER THROUGHOUT PARTICLE MONTELL NORTH AMERICA INC. (US) 1997-07-29 US disclosed
EP-0781551-A1 Retinoid formulations in porous microspheres for reduced irritation and enhanced stability Advanced Polymer Systems, Inc. (US) 1997-07-02 EP disclosed
EP-0612241-A4 IONIC BEADS USEFUL FOR CONTROLLED RELEASE AND ADSORPTION. ADVANCED POLYMER SYSTEMS INC (US) 1997-03-05 EP disclosed
US-5539057-A CATALYTIC GRAFT POLYMERIZATION OF OLEFINS WITH VINYL MONOMERS MONTELL NORTH AMERICA INC. (US) 1996-07-23 US disclosed
EP-0439079-B1 Method of producing olefin polymer graft copolymers MONTELL NORTH AMERICA INC (US) 1996-04-03 EP disclosed
US-5487959-A LITHIUM ELECTROLYTE AND ELECTROLYTE SEPARATOR VALENCE TECHNOLOGY, INC. 1996-01-30 US disclosed
EP-0665248-A1 A process for sequentially grafting olefin polymer materials and grafted polymers therefrom MONTELL NORTH AMERICA INC. (US) 1995-08-02 EP disclosed
US-5411994-A Graft copolymers of polyolefins and a method of producing same HIMONT INCORPORATED (US) 1995-05-02 US disclosed
EP-0437808-B1 Graft copolymers of polyolefins and a method of producing same HIMONT INC (US) 1995-02-22 EP disclosed
EP-0612241-A1 IONIC BEADS USEFUL FOR CONTROLLED RELEASE AND ADSORPTION Advanced Polymer Systems, Inc. (US) 1994-08-31 EP disclosed
EP-0369741-B1 Cationic compositions for topical application ADVANCED POLYMER SYSTEMS INC (US) 1994-08-10 EP disclosed
EP-0375290-B1 Electrode apparatus for dialysis TOKUYAMA SODA KK (JP) 1994-05-25 EP disclosed
WO-1993007862-A1 IONIC BEADS USEFUL FOR CONTROLLED RELEASE AND ADSORPTION ADVANCED POLYMER SYSTEMS, INC. (US) 1993-04-29 WO disclosed
US-5140074-A Grafting unsaturated monomers onto polyolefins using free radical catalysts in an oxygen-free atmosphere HIMONT INCORPORATED (US) 1992-08-18 US disclosed
US-5049253-A Seamless, self-supporting tubular ion exchanger TOKUYAMA SODA KABUSHIKI KAISHA (JP) 1991-09-17 US disclosed
EP-0439079-A2 Method of producing olefin polymer graft copolymers MONTELL NORTH AMERICA INC. (US) 1991-07-31 EP disclosed
EP-0437808-A2 Graft copolymers of polyolefins and a method of producing same Himont Incorporated (US) 1991-07-24 EP disclosed
EP-0375290-A2 Electrode apparatus for dialysis TOKUYAMA SODA KABUSHIKI KAISHA (JP) 1990-06-27 EP disclosed
EP-0369741-A2 Cationic compositions for topical application Advanced Polymer Systems, Inc. (US) 1990-05-23 EP disclosed
EP-0164270-B1 PHOTO-POLYMERIZABLE COMPOSITON AND PRINTING PLATE PREPARED THEREFROM NAPP SYSTEMS INC. (US) 1990-05-02 EP disclosed
US-4686243-A ADDITION POLYMERS OF HETEROCYCLES, DIALLYLDIALKYLAMMONIUM HALIDES, EPOXIDES OR AZIRIDINES HOECHST AKTIENGESELLSCHAFT (DE) 1987-08-11 US disclosed
US-4680357-A ADHESIVES THE DOW CHEMICAL COMPANY (US) 1987-07-14 US disclosed
EP-0131179-B1 COPOLYMER, PROCESS FOR ITS PREPARATION AND ITS USE AS A SORBENT CASSELLA Aktiengesellschaft (DE) 1987-06-16 EP disclosed
EP-0220593-A1 Copolymer, process for its preparation and its use in the bonding of enzymes HOECHST AKTIENGESELLSCHAFT (DE) 1987-05-06 EP disclosed
US-4638092-A POLYMERIZATION INIATOR; INCREASED STABILITY IN OXYGEN ATMOSPHERE HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1987-01-20 US disclosed
EP-0164270-A2 Photo-polymerizable compositon and printing plate prepared therefrom NAPP SYSTEMS INC. (US) 1985-12-11 EP disclosed
US-4552905-A VINYL-SUBSTITUTED PYRIDINE, QUINOLINE, ISO-QUINOLINE, OR PYRAZINE;N-VINYLAMIDE, CROSSLINKER CASSELLA AKTIENGESELLSCHAFT (DE) 1985-11-12 US disclosed
EP-0131179-A1 Copolymer, process for its preparation and its use as a sorbent CASSELLA Aktiengesellschaft (DE) 1985-01-16 EP disclosed
US-4398346-A COATING WITH ORGANIC COATING AND HEATING MEDTRONIC, INC. (US) 1983-08-16 US disclosed
US-4385439-A Method of making a lithium-iodine cell WILSON GREATBATCH, LTD. (US) 1983-05-31 US disclosed
US-4359818-A BONDING A POLYMER FILM ON A LITHIUM ELEMENT AND PRESSING IN A MOLD WILSON GREATBATCH LTD. (US) 1982-11-23 US disclosed
US-4307509-A Method for manufacturing a lithium-chlorine cell ELEANOR & WILSON GREATBATCH FOUNDATION (US) 1981-12-29 US disclosed
US-4211832-A Lithium-halogen cell including monomer charge transfer complex WILSON GREATBATCH LTD. (US) 1980-07-08 US disclosed
US-4210708-A Lithium-iodine cell WILSON GREATBATCH LTD. (US) 1980-07-01 US disclosed
US-4203201-A Methods for making lithium-iodine cell WILSON GREATBATCH LTD. (US) 1980-05-20 US disclosed
US-4166887-A Lithium halogen cell including activated charcoal WILSON GREATBATCH LTD. (US) 1979-09-04 US disclosed
US-4166158-A LITHIUM-IODINE CELL WILSON GREATBATCH LTD. (US) 1979-08-28 US disclosed
US-4164070-A ELECTROCONDUCTIVE CASING AS CATHODE CURRENT COLLECTOR ELEANOR & WILSON GREATBATCH FOUNDATION (US) 1979-08-14 US disclosed
US-4147842-A PYRIDINIUM BROMIDE-BROMINE CHARGE TRANSFER COMPLEX CATHODE ELEANOR & WILSON GREATBATCH FOUNDATION (US) 1979-04-03 US disclosed
US-4135519-A Cardiac pacer having alkali metal-halogen cell with mixed halogen cathode GREATBATCH W 1979-01-23 US disclosed
US-4132836-A TWO STEP OUTPUT VOLTAGE ELEANOR & WILSON GREATBATCH FOUNDATION (US) 1979-01-02 US disclosed
US-4128703-A Lithium-iodine cell WILSON GREATBATCH LTD. (US) 1978-12-05 US disclosed
US-4105833-A Lithium-bromine cell ELEANOR & WILSON GREATBATCH FOUNDATION (US) 1978-08-08 US disclosed
US-4071662-A POLYVINYLPYRIDINE WILSON GREATBATCH LTD. (US) 1978-01-31 US disclosed
US-4058889-A Method of making a lithium-bromine cell ELEANOR & WILSON GREATBATCH FOUNDATION (US) 1977-11-22 US disclosed
US-3994747-A Lithium-bromine cell ELEANOR & WILSON GREATBATCH FOUNDATION (US) 1976-11-30 US disclosed
US-3957533-A Lithium-iodine battery having coated anode WILSON GREATBATCH LTD. (US) 1976-05-18 US disclosed
US-3957533-A Lithium-iodine battery having coated anode WILSON GREATBATCH LTD. (US) 1976-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (30 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029610-A1 Heteroaryl Compounds and Uses Thereof ABCG2, CYP3A43, CYP3A5 LMNA 2409/4885SMN1; SMN2 2352/4885L3MBTL1 3899/4885
US-20230043970-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS BRAF, PIK3CA, PLK1 LMNA 1523/4885SMN1; SMN2 4283/4885L3MBTL1 3738/4885
US-12018002-B2 Certain chemical entities, compositions, and methods BRAF, PIK3CA, PLK1 LMNA 1523/4885SMN1; SMN2 4283/4885L3MBTL1 3738/4885
US-20130065892-A1 HETEROARYL COMPOUNDS AND USES THEREOF ABCG2, CYP3A43, CYP3A5 LMNA 2409/4885SMN1; SMN2 2352/4885L3MBTL1 3899/4885
US-20200247762-A1 K-RAS MODULATORS KRAS, HRAS, NRAS LMNA 4191/4885SMN1; SMN2 4529/4885L3MBTL1 1260/4885
US-20120190614-A1 HCV PROTEASE INHIBITORS AND USES THEREOF PEPD, CTRL, CTSC LMNA 3795/4885SMN1; SMN2 4140/4885L3MBTL1 3561/4885
US-20230148061-A1 TEAD INHIBITORS AND USES THEREOF TEAD2, TEAD3, TEAD4 LMNA 2907/4885SMN1; SMN2 3736/4885L3MBTL1 3224/4885
US-20080300268-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF ABCG2, CYP3A5, CYP3A43 LMNA 1530/4885SMN1; SMN2 2155/4885L3MBTL1 4683/4885
US-20100069294-A1 HCV PROTEASE INHIBITORS AND USES THEREOF PEPD, CTRL, CTSC LMNA 3795/4885SMN1; SMN2 4140/4885L3MBTL1 3561/4885
US-20100249092-A1 HETEROARYL COMPOUNDS AND USES THEREOF ABCG2, CYP3A43, CYP3A5 LMNA 2409/4885SMN1; SMN2 2352/4885L3MBTL1 3899/4885
US-20090176858-A1 HCV PROTEASE INHIBITORS AND USES THEREOF PEPD, CTRL, CTSC LMNA 3795/4885SMN1; SMN2 4140/4885L3MBTL1 3561/4885
US-11358940-B2 K-Ras modulators KRAS, HRAS, NRAS LMNA 4093/4885SMN1; SMN2 4514/4885L3MBTL1 3380/4885
US-20090137588-A1 HETEROARYL COMPOUNDS AND USES THEREOF ABCG2, CYP3A43, CYP3A5 LMNA 2409/4885SMN1; SMN2 2352/4885L3MBTL1 3899/4885
US-20110230476-A1 PI3 KINASE INHIBITORS AND USES THEREOF PIK3CA, PIK3CB, PIK3C2B LMNA 3776/4885SMN1; SMN2 3609/4885L3MBTL1 1825/4885
US-20130072469-A1 HETEROARYL COMPOUNDS AND USES THEREOF ABCG2, CYP3A43, CYP3A5 LMNA 2409/4885SMN1; SMN2 2352/4885L3MBTL1 3899/4885
US-20100016296-A1 HETEROARYL COMPOUNDS AND USES THEREOF ABCG2, CYP3A43, CYP3A5 LMNA 2409/4885SMN1; SMN2 2352/4885L3MBTL1 3899/4885
US-20120258967-A1 PI3 KINASE INHIBITORS AND USES THEREOF PIK3CA, PIK3CB, PIK3C2B LMNA 3776/4885SMN1; SMN2 3609/4885L3MBTL1 1825/4885
US-10857140-B2 K-Ras modulators KRAS, HRAS, NRAS LMNA 4067/4885SMN1; SMN2 4567/4885L3MBTL1 1943/4885
US-20200255446-A1 COMPOSITIONS AND METHODS FOR TREATING CANCER KRAS, HRAS, NRAS LMNA 2600/4885SMN1; SMN2 3432/4885L3MBTL1 3338/4885
US-20110224432-A1 HETEROARYL COMPOUNDS AND USES THEREOF ABCG2, CYP3A43, CYP3A5 LMNA 2409/4885SMN1; SMN2 2352/4885L3MBTL1 3899/4885
US-20090306085-A1 HCV PROTEASE INHIBITORS AND USES THEREOF PEPD, CTRL, CTSC LMNA 3795/4885SMN1; SMN2 4140/4885L3MBTL1 3561/4885
US-20130065899-A1 HETEROARYL COMPOUNDS AND USES THEREOF ABCG2, CYP3A43, CYP3A5 LMNA 2409/4885SMN1; SMN2 2352/4885L3MBTL1 3899/4885
US-11008334-B2 Compositions and methods for treating cancer KRAS, HRAS, NRAS LMNA 2600/4885SMN1; SMN2 3432/4885L3MBTL1 3338/4885
US-20100185419-A1 ALGORITHM FOR DESIGNING IRREVERSIBLE INHIBITORS CDKN1A, SERPINB1, SPR LMNA 4597/4885SMN1; SMN2 4842/4885L3MBTL1 612/4885
US-20110230494-A1 HETEROARYL COMPOUNDS AND USES THEREOF ABCG2, CYP3A43, CYP3A5 LMNA 2409/4885SMN1; SMN2 2352/4885L3MBTL1 3899/4885
US-20120238593-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF ABCG2, CYP3A5, CYP3A43 LMNA 1530/4885SMN1; SMN2 2155/4885L3MBTL1 4683/4885
US-20100041674-A1 HCV PROTEASE INHIBITORS AND USES THEREOF PEPD, CTRL, CTSC LMNA 3795/4885SMN1; SMN2 4140/4885L3MBTL1 3561/4885
US-20100041591-A1 HCV PROTEASE INHIBITORS AND USES THEREOF PEPD, CTRL, CTSC LMNA 3795/4885SMN1; SMN2 4140/4885L3MBTL1 3561/4885
US-20110117073-A1 Protein Kinase Conjugates and Inhibitors MAP3K20, PACSIN2, MAP3K9 LMNA 4241/4885SMN1; SMN2 4750/4885L3MBTL1 2167/4885
US-20130017991-A1 HCV PROTEASE INHIBITORS AND USES THEREOF PEPD, CTRL, CTSC LMNA 3795/4885SMN1; SMN2 4140/4885L3MBTL1 3561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.